Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study (Q34528336)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study |
scientific article |
Statements
1 reference
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study (English)
1 reference
Frederick R Appelbaum
1 reference
Cheryl L Willman
1 reference
Jeanne E Anderson
1 reference
Kenneth J Kopecky
1 reference
David Head
1 reference
Margaret R O'Donnell
1 reference
Frederick W Luthardt
1 reference
Thomas H Norwood
1 reference
I-Ming Chen
1 reference
Stanley P Balcerzak
1 reference
David B Johnson
1 reference
1 August 2002
1 reference
Identifiers
1 reference